ATAI Life Sciences NV (9VC)
TG
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Return on Assets (%) | -45.521 | -195.6 | -63.84 | -42.352 | -13.432 |
Return on Equity (%) | -47.413 | -219.144 | -69.727 | -46.764 | -15.772 |
Return on Invested Capital (%) | -92.079 | -168.258 | -60.064 | -48.282 | -60.04 |
Operating Margin (%) | N/A | N/A | -670.401 | -58018.026 | -11665.605 |
Net Profit Margin (%) | N/A | N/A | -823.557 | -65401.288 | -12810.191 |
Book Value Per Share | 10.52 | 13.299 | 2.402 | 1.602 | 1.472 |
Earnings Per Share | -2.494 | -23.685 | -1.044 | -0.918 | -0.242 |
Cash Per Share | 5.303 | 13.561 | 2.255 | 1.149 | 0.271 |
Working Capital Per Share | 6.622 | 12.167 | 2.204 | 1.611 | 0.997 |
Operating Profit Per Share | N/A | N/A | 0.127 | 0.001 | 0.002 |
EBIT Per Share | -3.082 | -14.198 | -0.85 | -0.815 | -0.237 |
EBITDA Per Share | -3.082 | -14.198 | -0.85 | -0.815 | -0.237 |
Free Cash Flow Per Share | -2.491 | -23.676 | -1.043 | -0.914 | -0.241 |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A |
Shares Outstanding | 5.67M | 7.17M | 160.68M | 165.94M | 166.03M |
Market Cap | 278.38M |
Price to Earnings Ratio | -7.01 |
Price to Sales Ratio | 884.21 |
Price to Cash Ratio | 6.26 |
Price to Book Ratio | 1.15 |
Dividend Yield | - |
Shares Outstanding | 167.8M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.